Literature DB >> 9792260

Use of coronary angiography and revascularization procedures following acute myocardial infarction. A European perspective.

K L Woods1, D Ketley, A Agusti, C Hagn, R Kala, N B Karatzas, A Leizorowicz, A Reikvam, J Schilling, R Seabra-Gomes, D Vasiliauskas, L Wilhelmsen.   

Abstract

AIMS: There is little evidence to inform routine practice in the use of coronary angiography and revascularization procedures after acute myocardial infarction. Large differences in the uptake of these procedures have been reported but representative data are scarce. Outcome studies have produced opposing conclusions concerning the impact of the high rate of these cardiac procedures. METHODS AND
RESULTS: A population-based patient sampling approach was utilized to identify routine practice in representative samples from 11 European countries. Data were collected retrospectively on treatment in the 6 months following acute myocardial infarction (n=2807). There was wide variation in utilization of coronary angiography and revascularization procedures. Even after restricting the analysis to patients <65 years (n=1262), there remained a 6 13 fold variation in the use of these procedures. A decreased likelihood of undergoing these procedures was associated with older age. In addition, there was an independent and negative association between female sex and utilization of coronary angiography and coronary artery bypass grafting (CABG).
CONCLUSION: The effect on patient outcome of the observed variation in use of these procedures is not known but has important cost and resource implications for the health services. Outcome research is needed to define patient selection criteria and to measure the cost-utility of different angiography and revascularization rates.

Entities:  

Mesh:

Year:  1998        PMID: 9792260     DOI: 10.1053/euhj.1998.1027

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  8 in total

1.  Prognostic assessment of uncomplicated first myocardial infarction by exercise echocardiography and Tc-99m tetrofosmin gated SPECT.

Authors:  J Candell-Riera; J Llevadot; C Santana; J Castell; S Aguadé; L Armadans; B Bermejo; G Oller; H García-del-Castillo; M Soler-Peter; J Soler-Soler
Journal:  J Nucl Cardiol       Date:  2001 Mar-Apr       Impact factor: 5.952

2.  Population need for coronary revascularisation: are national targets for England credible?

Authors:  R M Martin; H Hemingway; D Gunnell; K R Karsch; A Baumbach; S Frankel
Journal:  Heart       Date:  2002-12       Impact factor: 5.994

3.  Age difference explains gender difference in cardiac intervention rates after acute myocardial infarction.

Authors:  Randall R Fransoo; Patricia J Martens; Heather J Prior; Elaine Burland; Dan Château; Alan Katz
Journal:  Healthc Policy       Date:  2010-08

4.  Sex differences in coronary catheterization and revascularization following acute myocardial infarction: time trends from 1994 to 2003 in British Columbia.

Authors:  Tara L Sedlak; Aihua Pu; Eve Aymong; Min Gao; Nadia Khan; Hude Quan; Karin H Humphries
Journal:  Can J Cardiol       Date:  2010 Aug-Sep       Impact factor: 5.223

Review 5.  Abciximab. A pharmacoeconomic review of its use in percutaneous coronary revascularisation.

Authors:  C J Dunn; R H Foster
Journal:  Pharmacoeconomics       Date:  1999-12       Impact factor: 4.981

6.  Routine coronary angiographic follow-up and subsequent revascularization in patients with acute myocardial infarction.

Authors:  Katsunori Shimada; Hiroshi Kasanuki; Nobuhisa Hagiwara; Hiroshi Ogawa; Naohito Yamaguchi
Journal:  Heart Vessels       Date:  2008-11-27       Impact factor: 2.037

7.  Effects of captopril and valsartan on ventricular remodeling and inflammatory cytokines after interventional therapy for AMI.

Authors:  Xiaona Gong; Raorao Zhou; Qinhao Li
Journal:  Exp Ther Med       Date:  2018-08-20       Impact factor: 2.447

8.  Effects of tirofiban on stent thrombosis, Hs-CRP, IL-6 and sICAM-1 after PCI of acute myocardial infarction.

Authors:  Yuqing Zhang; Tingguo Shao; Lei Yao; Hong Yue; Zhiyu Zhang
Journal:  Exp Ther Med       Date:  2018-08-08       Impact factor: 2.447

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.